Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry.
Saved in:
| Title: | Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry. |
|---|---|
| Authors: | Martín M; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain. mmartin@geicam.org.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain. mmartin@geicam.org.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. mmartin@geicam.org., Carrasco E; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Rodríguez-Lescure Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital General Universitario de Elche, Elche, Spain., Andrés R; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain., Servitja S; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital del Mar, Barcelona, Spain., Antón A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital Universitario Miguel Servet, Universidad de Zaragoza, Instituto Investigación Sanitaria Aragón (IISA), Zaragoza, Spain., Ruiz-Borrego M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Virgen del Rocío, Sevilla, Spain., Bermejo B; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA. Universidad de Valencia, Valencia, Spain., Guerrero Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Instituto Valenciano de Oncología, Valencia, Spain., Ramos M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro Oncológico de Galicia, A Coruña, Spain., Santaballa A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario La Fe, Valencia, Spain., Muñoz M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Department of Medical Oncology and Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Cruz J; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Lopez-Tarruella S; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain., Chacón JI; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Toledo, Toledo, Spain., Álvarez I; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital de Donostia, San Sebastian, Spain., Martínez P; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Basurto, Bilbao, Spain., Miralles JJ; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Polonio Ó; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Jara C; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Fundación Alcorcón, Alcorcón, Spain., Aguiar-Bujanda D; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Sep; Vol. 201 (2), pp. 151-159. Date of Electronic Publication: 2023 Jun 20. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
